» Authors » Nyree Griffin

Nyree Griffin

Explore the profile of Nyree Griffin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 474
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Goh V, Mallett S, Boulter V, Glynne-Jones R, Khan S, Lessels S, et al.
Eur Radiol . 2024 Jun; 34(11):6992-7001. PMID: 38836939
Objective: Improving prognostication to direct personalised therapy remains an unmet need. This study prospectively investigated promising CT, genetic, and immunohistochemical markers to improve the prediction of colorectal cancer recurrence. Material...
2.
Hainsworth A, Premakumar Y, Griffin N, Solanki D, Morris S, Ferrari L, et al.
Colorectal Dis . 2023 Aug; 25(10):2001-2009. PMID: 37574701
Aim: The aim of this work was to determine the range of normal imaging features during total pelvic floor ultrasound (TPFUS) (transperineal, transvaginal, endovaginal and endoanal) and defaecation MRI (dMRI)....
3.
Mathew L, Goldenberg S, Griffin N, Ferguson F, de la Roche H, Hay I, et al.
Int J Dermatol . 2023 Feb; 62(7):e394-e396. PMID: 36732914
No abstract available.
4.
Luber R, Petri B, Meade S, Honap S, Zeki S, Gecse K, et al.
Frontline Gastroenterol . 2022 Dec; 14(1):52-58. PMID: 36561789
Objective: Intestinal ultrasound (IUS) is an inexpensive, non-invasive method of diagnosing and monitoring inflammatory bowel disease (IBD). We aimed to establish the proportion of lower gastrointestinal endoscopies (LGIEs) and magnetic...
5.
Meade S, Patel K, Luber R, OHanlon D, Caracostea A, Pavlidis P, et al.
Aliment Pharmacol Ther . 2022 Jun; 56(4):646-663. PMID: 35723622
Background: Low-quality evidence suggests that pre-operative exclusive enteral nutrition (E/EN) can improve postoperative outcomes in patients with Crohn's disease (CD). It is not standard practice in most centres. Aims: To...
6.
Bott R, George G, McEwen R, Zylstra J, Knight W, Baker C, et al.
Acta Oncol . 2021 Oct; 60(12):1629-1636. PMID: 34613874
Background: Neoadjuvant chemotherapy is often used prior to surgical resection for oesophageal adenocarcinoma but remains ineffective in a high proportion of patients. The histological Mandard tumour regression grade is used...
7.
Knight W, Baker C, Griffin N, Wulaningsih W, Kelly M, Davies A, et al.
Br J Cancer . 2021 Mar; 124(10):1653-1660. PMID: 33742143
Background: A high Mandard score implies a non-response to chemotherapy in oesophageal adenocarcinoma. However, some patients exhibit tumour volume reduction and a nodal response despite a high score. This study...
8.
Griffin N
Semin Ultrasound CT MR . 2020 Jul; 41(4):333. PMID: 32620222
No abstract available.
9.
Dellaportas D, Zylstra J, Gossage J, Baker C, Kelly M, Van Hemelrijck M, et al.
Chirurgia (Bucur) . 2019 Sep; 114(4):443-450. PMID: 31511130
To evaluate the prognostic role of Positron Emission Tomography/Computed Tomography (PET/CT) and Endoscopic Ultrasound (EUS) performed before neoadjuvant chemotherapy (NAC) and surgery for oesophageal adenocarcinoma (OAC) patients, focusing on lymph...
10.
Kotha S, Griffin N, Berry P
Gastroenterology . 2019 Aug; 158(1):e12-e13. PMID: 31376389
No abstract available.